Literature DB >> 32185587

Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner.

Giovanna Panzironi1,2, Giuliana Moffa3, Francesca Galati3, Flaminia Marzocca3, Veronica Rizzo3, Federica Pediconi3.   

Abstract

PURPOSE: To determine whether there is a correlation between the presence of peritumoral edema detected on T2-weighted sequences and pathological prognostic factors and specific biological subtypes of breast cancer.
METHODS: A retrospective study on 120 women with invasive breast cancer, who underwent breast MRI on a 3 T scanner over a period of 12 months, was performed. Peritumoral edema was assessed visually by two breast radiologist in consensus and patients were consequently divided into two groups. For each lesion dimensions, histology and molecular profiling were evaluated. The comparison between the two groups was performed using the χ2 test, subsequently carrying out a univariate and a multivariate logistic regression analysis.
RESULTS: 41 (34.2%) invasive breast cancers with perilesional edema and 79 (65.8%) without edema were identified. A significant association between the presence of perilesional edema and a larger lesion size (p = 0.0001), grade 3 (p < 0.001) and a higher Ki-67 index (p < 0.001) was found. The multivariate analysis confirmed that a larger tumor size is independently associated with peritumoral edema. A total of 101 (84.2%) luminal-like, 8 (6.7%) HER2-positive, and 11 (9.2%) triple-negative tumors were included in the study. Peritumoral edema turned out to be less frequently associated with luminal-like lesions (p < 0.001), while the luminal A status was found to have a significant association with the absence of peritumoral edema in the univariate analysis.
CONCLUSION: The detection of peritumoral edema on T2-weighted sequences should be considered as a valid additional prognostic tool in the evaluation of breast cancer, since it is associated with biologically aggressive non-luminal breast cancers, characterized by large dimension, high tumor grade, and high Ki-67 values.

Entities:  

Keywords:  Breast cancer; Magnetic resonance imaging; Peritumoral edema; Prognosis; T2-weighted images

Year:  2020        PMID: 32185587     DOI: 10.1007/s10549-020-05592-8

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  1 in total

1.  Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.

Authors:  Patrick L Fitzgibbons; Douglas A Murphy; M Elizabeth H Hammond; D Craig Allred; Paul N Valenstein
Journal:  Arch Pathol Lab Med       Date:  2010-06       Impact factor: 5.534

  1 in total
  11 in total

1.  A retrospective review of MRI features associated with metastasis-free survival in women with breast cancer: focusing on skin thickening and skin enhancement.

Authors:  Valentine Mberu; Jennifer McFarlane; E Jane Macaskill; Andrew Evans
Journal:  Br J Radiol       Date:  2021-10-05       Impact factor: 3.039

2.  Preoperative Staging in Breast Cancer: Intraindividual Comparison of Unenhanced MRI Combined With Digital Breast Tomosynthesis and Dynamic Contrast Enhanced-MRI.

Authors:  Veronica Rizzo; Giuliana Moffa; Endi Kripa; Claudia Caramanico; Federica Pediconi; Francesca Galati
Journal:  Front Oncol       Date:  2021-05-04       Impact factor: 6.244

3.  Dynamic contrast enhanced-MRI and diffusion-weighted image as predictors of lymphovascular invasion in node-negative invasive breast cancer.

Authors:  Bo Bae Choi
Journal:  World J Surg Oncol       Date:  2021-03-15       Impact factor: 2.754

Review 4.  The Breast Edema Enigma: Features, Diagnosis, Treatment, and Recommendations.

Authors:  Sarina S Gupta; Harvey N Mayrovitz
Journal:  Cureus       Date:  2022-04-03

Review 5.  MRI as a biomarker for breast cancer diagnosis and prognosis.

Authors:  Francesca Galati; Veronica Rizzo; Rubina Manuela Trimboli; Endi Kripa; Roberto Maroncelli; Federica Pediconi
Journal:  BJR Open       Date:  2022-05-26

Review 6.  Diffusion Breast MRI: Current Standard and Emerging Techniques.

Authors:  Ashley M Mendez; Lauren K Fang; Claire H Meriwether; Summer J Batasin; Stéphane Loubrie; Ana E Rodríguez-Soto; Rebecca A Rakow-Penner
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

7.  Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

Authors:  Francesca Galati; Veronica Rizzo; Giuliana Moffa; Claudia Caramanico; Endi Kripa; Bruna Cerbelli; Giulia D'Amati; Federica Pediconi
Journal:  Eur Radiol Exp       Date:  2022-08-08

8.  Peritumoral edema in breast cancer at preoperative MRI: an interpretative study with histopathological review toward understanding tumor microenvironment.

Authors:  Nora Jee-Young Park; Ji Yun Jeong; Ji Young Park; Hye Jung Kim; Chan Sub Park; Jeeyeon Lee; Ho Yong Park; Jin Hyang Jung; Wan Wook Kim; Yee Soo Chae; Soo Jung Lee; Won Hwa Kim
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

9.  Desensitization of Capsaicin-Sensitive Afferents Accelerates Early Tumor Growth via Increased Vascular Leakage in a Murine Model of Triple Negative Breast Cancer.

Authors:  Noémi Bencze; Csaba Schvarcz; Gábor Kriszta; Lea Danics; Éva Szőke; Péter Balogh; Árpád Szállási; Péter Hamar; Zsuzsanna Helyes; Bálint Botz
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

10.  Special Issue "Advances in Breast MRI".

Authors:  Francesca Galati; Rubina Manuela Trimboli; Federica Pediconi
Journal:  Diagnostics (Basel)       Date:  2021-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.